Cargando…
mTOR inhibitor use in head and neck squamous cell carcinoma: A meta‐analysis on survival, tumor response, and toxicity
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) has been rising in incidence primarily related to HPV‐associated oropharyngeal cancers. Novel molecular therapeutics are evolving with the mTOR pathway as a new target. Previous studies have shown variable outcomes with relatively low toxicit...
Autores principales: | Patel, Jaimin, Nguyen, Shaun A., Ogretmen, Besim, Gutkind, Jorge S., Nathan, Cherie‐Ann, Day, Terry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178455/ https://www.ncbi.nlm.nih.gov/pubmed/32337356 http://dx.doi.org/10.1002/lio2.370 |
Ejemplares similares
-
Head and neck cancer survivorship consensus statement from the American Head and Neck Society
por: Goyal, Neerav, et al.
Publicado: (2021) -
Microvessel density in head and neck squamous cell carcinoma
por: Szafarowski, Tomasz, et al.
Publicado: (2018) -
Acupuncture for radiation-induced toxicity in head and neck squamous cell carcinoma: a systematic review based on PICO criteria
por: Bonomo, Pierluigi, et al.
Publicado: (2021) -
Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma
por: Arron, Sarah T., et al.
Publicado: (2022) -
Body composition analysis in head and neck squamous cell carcinoma
por: Malecka-Massalska, Teresa, et al.
Publicado: (2013)